EIF2AK3 and diabetic kidney disease: One of these compounds, 4-phenylbutyric acid (4-PBA), a non-peptide chaperone that can reduce ER stress by suppressing BiP and PERK [61], reportedly prevents the progression of diabetic nephropathy.